Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Coursework PSOP CER

Student and faculty

Students must complete four courses for a total of 13 credit hours. The courses (listed below) are structured around the core methods used to study drug use in large populations. Students and faculty interact through online discussion groups and the use of virtual collaboration sessions. Participants are assessed by their participation in discussions and performance on quizzes and assignments.

This certificate can be earned in as few as two semesters (two courses each in the fall and spring semester) or can be spread out over a longer period (e.g., 4 semesters – one course per semester). To earn the certificate, students must maintain a 3.0 (out of 4.0) average for all program courses.

Each student will receive graduate credit for the classes successfully completed, which could be transferred toward the fulfillment of a Masters or PhD degree at UIC (e.g. Masters or PhD in Public Health Epidemiology, or in Pharmacy Systems, Outcomes and Policy, or other).

The following four courses are required for completion of the certificate program:

BSTT 400 – Biostatistics I (Fall)
Descriptive statistics, basic probability concepts, one- and two- sample statistical inference, analysis of variance, and simple linear regression. Introduction to statistical data analysis software.
EPID 403 – Introduction to Epidemiology: Principles and Methods (Fall)
Introduction to descriptive and analytic epidemiology, and determinants of health and disease in populations. Measures of occurrence, association, and statistical testing will be addressed, along with study designs, bias, and confounding.
PSOP 526 – Pharmacoepidemiology (Spring)
Provides an introduction to pharmacoepidemiology and key concepts and principles that are unique to the study of medications in large populations.
PSOP 535 – Pharmaceutical Policy (Spring)
Covers key features of health care and pharmaceutical policy, and provides a framework for analyzing and evaluating current policy issues that affect the development and provision of safe, effective and affordable medications in the U.S. and internationally.